The Early Impact of COVID-19 on the Incidence, Prevalence, and Severity of Alcohol Use and Other Drugs: A Systematic Review
Overview
Affiliations
Background: The aim of this paper was to examine the early impact of COVID-19 on substance use to assess implications for planning substance use treatment and support systems.
Method: A systematic review of literature published up to March 2021 was conducted to summarize changes in prevalence, incidence, and severity of substance use associated with COVID-19 and the accompanying public health measures, including lockdown, stay-at-home orders, and social distancing.
Results: We identified 53 papers describing changes to substance use at the population level. The majority of papers described changes related to alcohol use and most relied on self-reported measures of consumption during the COVID-19 pandemic, compared with pre-pandemic use. There was less evidence to support changes in non-alcohol substance use. In general, risky pre-pandemic alcohol use, caregiving responsibilities, stress, depression, anxiety, and current treatment for a mental disorder were found to be associated with increased substance use.
Conclusion: This review provides preliminary data on changes in substance use, indicating that certain segments of the population increased their alcohol use early on in the COVID-19 pandemic and may be at greater risk of harm and in need of additional services. There is a need for additional population-level information on substance use to inform evidence-based rapid responses from a treatment system perspective.
Heidrich N, Nin M, Almeida F, Constant H, Freese L, Barros H Front Psychiatry. 2025; 16:1514365.
PMID: 39980973 PMC: 11841454. DOI: 10.3389/fpsyt.2025.1514365.
Narvaez-Camargo M, Mancheno-Velasco C, Diaz-Batanero C, Fernandez-Calderon F, Lozano O Subst Use. 2025; 19():29768357241306717.
PMID: 39802982 PMC: 11724415. DOI: 10.1177/29768357241306717.
Roser P, Specka M, Bonnet U, Kuhlmann T, Kuhnhold S, Steinert R Front Psychiatry. 2024; 15:1467144.
PMID: 39737103 PMC: 11683050. DOI: 10.3389/fpsyt.2024.1467144.
Vergeer R, Luk J, Stangl B, McCabe E, Ziausyte U, Schwandt M Front Psychiatry. 2024; 15:1487277.
PMID: 39735429 PMC: 11672780. DOI: 10.3389/fpsyt.2024.1487277.
Calcaterra S, Mann S, Grimm E, Keniston A, Saunders S J Gen Intern Med. 2024; .
PMID: 39707083 DOI: 10.1007/s11606-024-09228-1.